Pellets & MUPS

Pellets, MUPS & DC Granules

Small, free-flowing spherical particles made by combining fine powders or granules of drugs and excipients — value-added semi-finished formulations for novel drug delivery systems.

Product

Type

Composition

CAS No.

Therapeutic use

Duloxetine HCl

17%, 20%, 22%, 22.5%

136434-34-9

Anti-Depressant

Esomeprazole

8.5%, 10%, 22.5%, 30%

217087-09-7

Anti-Ulcerant

Esomeprazole (Micro/MUPS)

8.5%, 15%, 22.5%

217087-09-7

Anti-Ulcerant

Lansoprazole

8.5%, 12%

103577-45-3

Anti-Ulcerant

Lansoprazole (Micro Pellets)

8.5%, 12.5%

103577-45-3

Anti-Ulcerant

Omeprazole

7.5%, 8.5%, 15%, 20%, 22.5%, 30%

73590-58-6

Anti-Ulcerant

Omeprazole (Micro Pellets)

8.5%, 10%, 20%, 22%, 22.5%

73590-58-6

Anti-Ulcerant

Pantoprazole

8.5%, 15%, 16%, 20%, 22%, 22.5%, 30%, 40%

102625-70-7

Anti-Ulcerant

Pancreatin

(Vegetative)

Enzyme Supplement

Rabeprazole

10%, 15%, 20%

117976-90-6

Anti-Ulcerant

Diclofenac Sodium

30%, 31.25%, 35%, 40%

15307-79-6

Anti-Inflammatory

Domperidone

5.5%, 10%

57808-66-9

Anti-emetic

Venlafaxine

32%, 33%

93413-69-5

Anti-Depressants

Aprepitant

40%

170729-80-3

Anti-Emetic

Dabigatran

35%, 40%

211915-06-9

Direct Thrombin Inhibitors

Diclofenac Sodium

30%, 31.25%, 35%, 40%

15307-79-6

Anti-Inflammatory

Domperidone

10%, 11%

57808-66-9

Anti-emetic

Itraconazole

20%, 22%, 40%, 44%

84625-61-6

Anti-fungal

Orlistat

50%

96829-58-2

Anti-Obesity

Clarithromycin Taste Masked Micro Pellets, Granules

Micro Pellets

27.5%, 30%, 33%, 42%, 43.75%

81103-11-9

Macrolide Antibiotics

Diclofenac Sodium

40%

15307-79-6

Anti-Inflammatory

Domperidone

20%, 30%, 22.0%, 22.5%

57808-66-9

Anti-emetic

Itopride HCl

60%

122892-31-3

Anti-emetic

Levosulpiride

50%

23672-07-3

Antipsychotic

Mebeverine HCl

54%, 60%, 70%, 80%, 90%, 96.38%

2753-45-9

Anti-spasmodic

Memantine

10.5%

19982-08-2

Anti-Alzheimer's

Mesalamine

54%, 70%, 90%, 96.38%

89-57-6

Anti-Inflammatory

Mesalamine (Premix/Granules)

70%, 90%, 96.38%

89-57-6

Anti-Inflammatory

Nicardipine

13%, 22%, 33%

55985-32-5

Anti-Hypertension

Tamsulosin HCl

0.1158%, 0.12%, 0.125%, 0.13%, 0.16%, 0.2%

106463-17-6

Adrenergic-alpha-antagonist

Vincamine

13%

1617-90-9

Anti-Hypertension

Dexlansoprazole

DDR

15%, 17%, 20%, 22.5%, 23%, 23.5%, 25%, 37%

138530-94-6

Anti-ulcerant

Barnidipine hydrochloride

10%

104757-53-1

Calcium channel blocker

Chlorpheneramine Maleate

6.72%, 8%

113-92-8

Anti-histamine

Cinitapride

66564-14-5

Antiemetic

Clarithromycin

27.5%, 30%, 33%, 42%, 43%, 43.75%

81103-11-9

Macrolide Antibiotics

Everolimus

2.68%

159351-69-6

Immunosupressant

Flurbiprofen

60%

5104-49-4

Anti-Inflammatory

Ketoprofen

60%

22071-15-4

Anti-Inflammatory

Levomilnacipran

38.71%, 38.83%, 39.21%

96847-55-1

Anti-depressant

Linaclotide

851199-59-2

Guanylate cyclase-C (GC-C) agonists

Memantine

11%

19982-08-2

NMDA Receptor Antagonist

Mesalamine

60%

89-57-6

Anti-Inflammatory

Metoprolol Succinate MUPS

60%, 66%, 58%

98455-82-6

Anti-Hypertension

Nicardipine

22%

55985-32-5

Anti-Hypertension

Pancreatin

10000/25000/40000-units

8049-47-6

Enzyme Supplement

Peppermint oil

23%

8006-90-4

Gastrointestinal agent / Anti-foaming agent

Sirolimus

0.3%, 0.6%, 1.2%

53123-88-9

Immunosupressant

Tacrolimus

0.5%, 1%, 5% & 20%

104987-11-3

Immunosupressant

Tolterodine Tartrate

2.10%

124937-52-6

Antimuscarinic agent

Trospium chloride

17.7%, 20%, 25%

10405-02-4

Antimuscarinic agent

Viloxazine

34%, 40%

46817-91-8

Selective norepinephrine reuptake inhibitor

Xanomeline Tartrate

50%, 66%, 68%

141064-23-5

Muscarinic acetylcholine receptor agonist

Carbonyl Iron

5% W/W

7439-89-6

Nutrient Deficiency Supplements

Zinc Sulphate

6.18% W/W

7446-20-0

Nutrient Deficiency Supplements

Folic Acid

0.05% W/W

59-30-3

Nutrient Deficiency Supplements

Digital Transformation

September 2026

AI Governance & Data Integrity at GPACTS 2026

Vasudha Pharma highlighted modern AI governance architectures, cGMP compliance, and data integrity at the Global Pharma AI Summit in Hyderabad.

State Recognition

May 2026

Best Management Award by Govt. of Andhra Pradesh

VPCL Unit-2 (Visakhapatnam / JN Pharma City) received the prestigious Best Management Award from the Government of Andhra Pradesh for excellence in industrial relations, worker safety, and statutory compliance.

View facilities →

Industry Excellence

2026

Best API Manufacturing Factory Award

Vasudha Pharma Chem Limited was recognized by the Government of Telangana with the Best API Manufacturing Factory Award for cGMP manufacturing excellence and quality leadership.

Learn more →

Company Update

Recent

Strong Credit Rating Affirmed

India Ratings & Research affirmed “IND A+/Stable/IND A1+” rating on Vasudha Pharma Chem Limited’s bank loan facilities.

Environment, health and safety practices

Sustainability

EHS Focus

EcoVadis Gold Level Recognition

Continued commitment to Environment, Health & Safety with strong sustainability ratings and low-risk certifications from global partners.

Community

Social Impact

Vasudha Foundation Initiatives

Our social service organization continues to extend physical and financial support to communities across all classes and age groups.

Interactive 3D Molecular Structure Visualizer

Loading molecule…

Pellets, MUPS & DC Granules

Events

CPHI Milan 2026

CPHI Milan 2026

Bio-Europe 2026

Bio-Europe 2026

CPHI India 2026

CPHI India 2026

DCAT Week 2027

DCAT Week 2027

Latest News & Insights

AI Governance & Data Integrity at GPACTS 2026

Best Management Award by Govt. of Andhra Pradesh

Best API Manufacturing Factory Award

Strong Credit Rating Affirmed

EcoVadis Gold Level Recognition

Vasudha Foundation Initiatives

Partner with a trusted API manufacturer